These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 1436127)

  • 1. Changes in cholecystokinin receptor binding in rat brain after selective damage of locus coeruleus projections by DSP-4 treatment.
    Harro J; Jossan SS; Oreland L
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Oct; 346(4):425-31. PubMed ID: 1436127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical analysis of the neurotoxic effects of DSP-4 identifies two populations of noradrenergic axon terminals.
    Fritschy JM; Grzanna R
    Neuroscience; 1989; 30(1):181-97. PubMed ID: 2747911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP4) on alpha2-adrenoceptors which regulate the synthesis and release of noradrenaline in the rat brain.
    Prieto M; Giralt MT
    Pharmacol Toxicol; 2001 Mar; 88(3):152-8. PubMed ID: 11245411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of low dose N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine administration on exploratory and amphetamine-induced behavior and dopamine D2 receptor function in rats with high or low exploratory activity.
    Alttoa A; Kõiv K; Eller M; Uustare A; Rinken A; Harro J
    Neuroscience; 2005; 132(4):979-90. PubMed ID: 15857703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective effects of DSP-4 on locus coeruleus axons: are there pharmacologically different types of noradrenergic axons in the central nervous system?
    Fritschy JM; Grzanna R
    Prog Brain Res; 1991; 88():257-68. PubMed ID: 1726027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholecystokinin peptides and receptor binding in rat brain after DSP-4 treatment.
    Löfberg C; Harro J; Matto V; Oreland L
    Neuropeptides; 1998 Apr; 32(2):103-8. PubMed ID: 9639247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overflow of noradrenaline and dopamine in frontal cortex after [N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine] (DSP-4) treatment: in vivo microdialysis study in anaesthetized rats.
    Kask A; Harro J; Tuomaine P; Rägo L; Männistö PT
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Feb; 355(2):267-72. PubMed ID: 9050022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic mild unpredictable stress after noradrenergic denervation: attenuation of behavioural and biochemical effects of DSP-4 treatment.
    Harro J; Häidkind R; Harro M; Modiri AR; Gillberg PG; Pähkla R; Matto V; Oreland L
    Eur Neuropsychopharmacol; 1999 Dec; 10(1):5-16. PubMed ID: 10647090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity and efficacy of noradrenaline, serotonin depletion in discrete brain areas of Swiss mice by neurotoxins.
    Dailly E; Chenu F; Petit-Demoulière B; Bourin M
    J Neurosci Methods; 2006 Jan; 150(1):111-5. PubMed ID: 16098600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of noradrenergic denervation by neonatal DSP-4 on peptide neurotransmitter systems in the rat brain.
    Donnerer J; Humpel C; Saria A
    Neuropeptides; 1992 Jun; 22(2):103-6. PubMed ID: 1357578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of parkinsonian symptoms by depletion of locus coeruleus noradrenaline in 6-hydroxydopamine-induced partial degeneration of substantia nigra in rats.
    Srinivasan J; Schmidt WJ
    Eur J Neurosci; 2003 Jun; 17(12):2586-92. PubMed ID: 12823465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recovery of central noradrenergic neurons one year after the administration of the neurotoxin DSP4.
    Wolfman C; Abó V; Calvo D; Medina J; Dajas F; Silveira R
    Neurochem Int; 1994 Oct; 25(4):395-400. PubMed ID: 7820072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A partial noradrenergic lesion induced by DSP-4 increases extracellular noradrenaline concentration in rat frontal cortex: a microdialysis study in vivo.
    Hughes ZA; Stanford SC
    Psychopharmacology (Berl); 1998 Apr; 136(3):299-303. PubMed ID: 9566816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of denervation of the locus coeruleus projections by DSP-4 treatment on [3H]-raclopride binding to dopamine D(2) receptors and D(2) receptor-G protein interaction in the rat striatum.
    Harro J; Terasmaa A; Eller M; Rinken A
    Brain Res; 2003 Jun; 976(2):209-16. PubMed ID: 12763255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the noradrenaline neurotoxin DSP4 on the postnatal development of central noradrenaline neurons in the rat.
    Jonsson G; Hallman H; Sundström E
    Neuroscience; 1982; 7(11):2895-907. PubMed ID: 7155358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effects of N-2-chlorethyl-N-ethyl-2-bromobenzylamine hydrochloride on noradrenergic neurones in the rat brain and heart.
    Ross SB
    Br J Pharmacol; 1976 Dec; 58(4):521-7. PubMed ID: 1000130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial denervation of the locus coeruleus projections by treatment with the selective neurotoxin DSP-4 potentiates the long-term effect of parachloroamphetamine on 5-hydroxytryptamine metabolism in the rat.
    Eller M; Harro J
    Neurosci Lett; 2002 Mar; 322(1):53-6. PubMed ID: 11958842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective Lifelong Destruction of Brain Monoaminergic Nerves Through Perinatal DSP-4 Treatment.
    Nowak P
    Curr Top Behav Neurosci; 2016; 29():51-71. PubMed ID: 26427851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective brain noradrenaline depletion induced by the neurotoxin N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP 4) does not prevent the memory facilitation induced by a muscarinic agonist in mice.
    Introini IB; Baratti CM; Huygens P
    Psychopharmacology (Berl); 1984; 82(1-2):107-12. PubMed ID: 6420819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noradrenergic denervation attenuates desipramine enhancement of aggressive behavior in isolated mice.
    Matsumoto K; Ojima K; Watanabe H
    Pharmacol Biochem Behav; 1995 Mar; 50(3):481-4. PubMed ID: 7617690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.